The side effect profiles of cagrilintide and retatrutide are broadly consistent with other incretin-based therapies, reflecting their shared mechanisms of action
This version produces a more natural, pulsatile release of growth hormone that closely mimics your bodys own rhythms, avoiding the prolonged, flat-line GH elevation associated with the DAC version
It consists of a chain of 15 amino acids and was first investigated in research exploring gastric mucosal protection and tissue repair
The bottom line on body composition is that neither treatment shows a clear advantage over the other based on available data
Thats why therapies such as platelet-rich plasma (PRP), platelet-rich fibrin (PRF), bone-marrow aspirate concentrate (BMAC), micro-fragmented adipose tissue (MFAT), and other orthobiologic/regenerative interventions, i.e., therapies that address the structure and not just the symptom, become the more appropriate clinical option in musculoskeletal applications
Efficacy and safety of cagrilintide with semaglutide in type 2 diabetes
